Clinical Trial Update: Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC [Phase 2]

View source ↗

Summary

A Phase II clinical trial recruiting to evaluate postoperative radiotherapy after neoadjuvant chemo-immunotherapy and surgery in stage III non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Non Small Cell Lung Cancer, Stage III Lung Cancer | Phase 2 | Status: RECRUITING